New Key Statistics Module, Z-Score and F-Score
NAS:SPRO Key Ratios
| Market Cap $ M | 65.81 |
| Enterprise Value $ M | 17.07 |
| P/E(ttm) | 10.27 |
| PE Ratio without NRI | 9.42 |
| Forward PE Ratio | 1.69 |
| Price/Book | 1.49 |
| Price/Sales | 1.77 |
| Price/Free Cash Flow | 3.03 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 42.00 |
| EPS (TTM) $ | 0.11 |
| Beneish M-Score | -3.93 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 2.58 |
| EV-to-EBITDA | 2.58 |
| PEG | -- |
| Shares Outstanding M | 58.23 |
| Net Margin (%) | 17.18 |
| Operating Margin % | 15.39 |
| Pre-tax Margin (%) | 17.79 |
| Quick Ratio | 6.12 |
| Current Ratio | 6.12 |
| ROA % (ttm) | 12.43 |
| ROE % (ttm) | 17.13 |
| ROIC % (ttm) | 55.11 |
| Dividend Yield % | -- |
| Altman Z-Score | -5.53 |
SPRO Number of Guru Trades
SPRO Volume of Guru Trades
Gurus Latest Trades with NAS:SPRO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:SPRO is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Spero Therapeutics Inc Insider Transactions
No Available Data
News about NAS:SPRO
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers